Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
151.70    -1.10 (-0.72%)
Bid:
151.30
Ask:
151.80
Spread: 0.50 (0.33%)
Market Cap: £383.63m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

COVID-19 update

27 Mar 2020 07:00

RNS Number : 7918H
Marshalls PLC
27 March 2020
 

27 March 2020

LEI: 213800S21IFC367J5V62

 

 

COVID-19 update

 

Marshalls plc, the specialist landscape products group, issues an update on the impact and the measures it is taking in response to the COVID-19 outbreak.

 

In view of the Government's increasing measures to contain the spread of the virus in the current challenging environment, the Group is taking actions to ensure the health and wellbeing of employees, customers and suppliers and to support the long-term interest of the business.

 

Operational actions

 

The Group is implementing an agile, operational plan to manage all parts of the business safely, whilst continuing to support customers where there is demand. We are continuing to distribute product where demand exists, but in those parts of the business where demand has fallen we are managing the manufacturing facilities carefully and commencing a process of temporary suspension of operations. These actions will protect cash flow generation and contain costs. Non-essential capital expenditure has been deferred, but not at the expense of health and safety. Our operational planning is dynamic and able to react to the changing environment. The majority of our office-based employees are now safely working from home. We are adhering closely to official UK Government guidance.

 

Financial position

 

The Group has a strong balance sheet supported by a flexible capital structure and we maintain significant headroom against bank facilities. We conduct deep stress testing on a regular basis to support this position. We have a range of committed facilities in place with a spread of maturity dates that extend out to 2024. The Group's total bank facilities are currently £165 million of which £140 million are committed. As at 25 March the Group had £93 million of net debt (on a pre-IFRS 16 basis) of which £82 million was committed. Consequently, £72 million of facilities remain unutilised of which £58 million is committed.

 

Our bank covenants are for the ratio of EBITA to interest charge to be greater than 2.5 times and for the ratio of net debt to EBITDA to be less than 3.0 times. All bank covenants are on a pre-IFRS 16 basis. Interest cover and net debt to EBITDA covenants were comfortably met for the year ended 31 December 2019 at 42.6 times and 0.2 times respectively.

 

We maintain positive and constructive relationships with all our banking partners. Our short term cash flows will also benefit from many of the initiatives announced by the Government.

 

2019 Final and Supplementary dividends

 

In the current circumstances, however, the Board believes it is important to preserve the Group's strong financial position and, consequently, that it is now appropriate to cancel the 2019 final dividend of 9.65 pence and the previously announced supplementary dividend of 4.00 pence. These were previously proposed with the announcement of the full year results for 2019 on 12 March 2020. As a result, the approval of these previously proposed dividends will not be put before shareholders at the AGM. The cash saving from this measure will be £27.1 million.

 

Outlook

 

As a consequence of the current levels of uncertainty, which are unprecedented, it is not possible at this time for the Group to provide an accurate assessment of trading for the current year and accordingly all previous market guidance is now being withdrawn. We will provide a further update when there is greater clarity about the impact of COVID-19.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

Enquiries:

Martyn Coffey

Chief Executive

Marshalls plc

+44 (0)1422 314777

Jack Clarke

Group Finance Director

 

Marshalls plc

+44 (0)1422 314777

Andrew Jaques

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

 

 

Note to the Editor:

 

About Marshalls:

 

Established in the late 1880s, Marshalls is the UK's leading manufacturer of superior natural stone and innovative concrete hard landscaping products, supplying the construction, home improvement and landscape markets. Marshalls provides the product ranges, design services, technical expertise, innovative ideas and inspiration to transform gardens, drives and public and commercial landscapes.

 

Marshalls operates its own quarries and manufacturing sites throughout the UK, including a national network of manufacturing and distribution sites, and has operations in Belgium and sales representation in other international markets. As a major plc, Marshalls is committed to quality in everything it does, including the achievement of high environmental and ethical standards and continual improvement in health and safety performance.

 

Forward-Looking Statements:

 

Any statements in this release, to the extent that they are forward-looking, are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the markets in which Marshalls operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. More information about the factors that may affect Marshalls' performance is contained in the Annual Report to shareholders for the year ended 31 December 2018.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEANDKADNEEFA
Date   Source Headline
2nd Oct 20231:08 pmRNSHolding(s) in Company
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSDirector/PDMR Shareholding
16th Aug 20237:00 amRNSHalf-year Report
2nd Aug 20238:49 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSTrading Statement
21st Jul 202311:25 amRNSDirector Declaration
19th Jul 202312:09 pmRNSDirector Declaration
13th Jul 20234:44 pmRNSDirector/PDMR Shareholding
13th Jul 20234:42 pmRNSDirector/PDMR Shareholding
13th Jul 20234:40 pmRNSDirector/PDMR Shareholding
26th Jun 20234:45 pmRNSDirector/PDMR Shareholding
26th Jun 20234:42 pmRNSDirector/PDMR Shareholding
21st Jun 20232:13 pmRNSHolding(s) in Company
25th May 20233:05 pmRNSHolding(s) in Company
12th May 20239:13 amRNSHolding(s) in Company
10th May 20234:48 pmRNSResult of AGM
10th May 202312:53 pmRNSResult of AGM
9th May 20231:06 pmRNSDirector/PDMR Shareholding
9th May 202312:31 pmRNSDirector/PDMR Shareholding
9th May 202310:34 amRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSTrading Statement
4th Apr 20238:57 amRNSAnnual Financial Report
29th Mar 202312:19 pmRNSEBT Share Purchase
20th Mar 20235:25 pmRNSDirector/PDMR Shareholding
17th Mar 20232:00 pmRNSHolding(s) in Company
17th Mar 20231:46 pmRNSDirector/PDMR Shareholding
17th Mar 202311:18 amRNSDirector/PDMR Shareholding
17th Mar 202311:17 amRNSDirector/PDMR Shareholding
17th Mar 20239:08 amRNSDirector/PDMR Shareholding
16th Mar 20232:49 pmRNSDirector/PDMR Shareholding
15th Mar 20232:45 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSFinal Results
10th Mar 20239:04 amRNSHolding(s) in Company
20th Feb 202310:42 amRNSHolding(s) in Company
16th Feb 202311:42 amRNSHolding(s) in Company
6th Feb 202311:23 amRNSHolding(s) in Company
3rd Feb 202312:51 pmRNSHolding(s) in Company
1st Feb 20232:21 pmRNSDirector/PDMR Shareholding
27th Jan 20231:32 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSTrading Statement
13th Jan 20231:55 pmRNSHolding(s) in Company
8th Nov 20222:12 pmRNSDirectorate Change
8th Nov 202212:01 pmRNSHolding(s) in Company
25th Oct 20224:27 pmRNSHolding(s) in Company
7th Oct 20223:36 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTrading Statement
22nd Sep 20227:00 amRNSCapital Markets Day
19th Aug 20223:36 pmRNSDirector/PDMR Shareholding
18th Aug 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.